Nestmedic (WAR:NST) Moat Score: 0/10 (As of Jul. 04, 2026)


WAR:NST Nestmedic SA WAR:NST
40 GF Score
Price zł0.73
GF Value zł0.42
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nestmedic Moat Score?

Nestmedic has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Nestmedic has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Nestmedic might have No Moat - No discernible moat.

Nestmedic  (WAR:NST) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Nestmedic Moat Score Related Terms

WAR:NST
40GF Score
Nestmedic SA WAR:NST
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nestmedic (WAR:NST) Overvalued in 2026?

Based on GuruFocus' analysis, Nestmedic stock appears to be overvalued. The current stock price of zł0.73 is trading 73.3% above its estimated GF Value™ of zł0.42. GuruFocus considers Nestmedic to be Significantly Overvalued.

Key valuation signals for WAR:NST:

  • Moat Score: 0
  • GF Value™: zł0.42 vs. price of zł0.73 (73.3% above fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the WAR:NST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nestmedic Business Description

Address ul. Pasymska 20, Warszawa, POL, 01-993
Nestmedic SA is a manufacturer of mobile telemedicine solution Pregnabit for remote fetal well-being - cardiotocographic (KTG). Pregnabit consists of a medical device (teleKTG) allowing to reliably and safely retrieve data using certified medical probes.
40GF Score

Get the complete analysis for WAR:NST

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.73
Price
zł0.42
GF Value